Sort
23,748 grants matching “melanoma”
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$540,239Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Developing new therapeutic strategies for brain metastasis
$540,115Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
3D Models of Immunotherapy
$540,107David J Mooney · Harvard University · U01 · FY2019 · CA
Sun Safety Ink! A Sun Safety Program for the Tattoo Community
$540,046Barbara Walkosz · Klein Buendel, Inc. · R01 · FY2017 · CA
MOUSE MODELS FOR HUMAN CANCER
$540,032University Of Wisconsin Madison · U01 · FY2003 · CA
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
$539,865Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Novel strategies to improve mesothelioma therapy
$539,493Haining Yang · University Of Hawaii At Manoa · R01 · FY2024 · CA
CAREER: Engineering Molecular Adjuvants for Cancer Vaccines
$539,422Haipeng Liu · Wayne State University · · FY2018 · ENG
Mechanisms of UVA-induced skin cancer
$539,336Yu-Ying He · University Of Chicago · R01 · FY2010 · ES
NIA Confocal Imaging Facility
$539,191Fred Indig · National Institute On Aging · ZIC · FY2014 · AG
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma
$539,037Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$538,983Justin M Balko · Vanderbilt University Medical Center · R01 · FY2019 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$538,890Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$538,785Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Analysis of galectin-8 and its ligands in melanoma progression
$538,782Charles J Dimitroff · Florida International University · R01 · FY2025 · CA
Elucidation of Human Natural Killer Cell Development
$538,711Aharon G Freud · Ohio State University · R01 · FY2024 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$538,665Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2025 · CA
Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s
$538,540Sean Vahram Tavtigian · University Of Utah · R01 · FY2023 · CA
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$538,465University Of Virginia Charlottesville · R37 · FY2001 · AI
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
$538,399Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$538,330Hai-Quan Mao · Johns Hopkins University · R01 · FY2024 · CA
DEVELOPMENTAL FUNDS (Core 002)
$538,114Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
DEVELOPMENTAL FUNDS (Core 002)
$538,114Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$537,945Theresa A Guise · Indiana University Indianapolis · U01 · FY2012 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$537,942Theresa A Guise · Indiana University Indianapolis · U01 · FY2015 · CA